A study to assess the efficacy, safety, pharmacokinetics, and related polymorphism of medicines for pulmonary arterial hypertension in pediatric patients
Not Applicable
- Conditions
- Pulmonary arterial hypertension
- Registration Number
- JPRN-UMIN000010355
- Lead Sponsor
- Department of clinical pharmacology and genetics, school of pharmaceutical science, university of Shizuoka graduate school
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess PK/PD based on plasma concentration of PAH medicines, as well as efficacy and safety in PAH pediatric patients.
- Secondary Outcome Measures
Name Time Method To explore gene polymorphisms relating to pharmacokinetics, efficacy, and safety of PAH medicines.